Clinical trial

Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)

NCT04305977

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BEHAVIORAL · Unmapped registry intervention WAVE-TW Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2020-10-22

PhaseNA

Conditions

PTSDverified · MONDO: post-traumatic stress disorder

Depressionverified · MONDO: depressive disorder

Virus, Human Immunodeficiencyunresolved

Interventions

WAVE-TWBEHAVIORAL

Sponsors & collaborators

University of Miamilead sponsor

Empower U Community Health Centercollaborator

Miami Center for AIDS Research at the University of Miami Miller School of Medicinecollaborator

Mapped research locations

MiamiFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04305977 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.